The Promise of Regeneration
Following the publication of his new book on regenerative medicine, Dr Patrick Treacy explores why it’s the new frontier in aesthetics
The idea that the body might heal itself is as old as medicine itself. Hippocrates, writing in the 5th century BC, believed that “nature itself is the best physician.” For centuries, physicians relied on that premise, supporting the body with poultices, herbs, or surgical dressings while trusting its inherent capacity for renewal. Yet the modern science of regeneration – the deliberate stimulation of cells, growth factors, and tissues – is a much more recent arrival, born of advances in cell biology, molecular genetics, and tissue engineering. In the nineteenth century, experimental surgeons began transplanting skin and cartilage, setting the first precedents for organ repair.
By the mid-twentieth century, bone marrow transplantation demonstrated that stem cells could restore not just tissue but an entire immune system. These were crude, risky procedures by modern standards, but they marked the moment medicine began to turn from repair to regeneration.
The real turning point came in the 1960s and 70s with the discovery and characterisation of stem cells. Researchers such as Till and McCulloch in Toronto demonstrated the self-renewing capacity of bone marrow cells, a discovery that earned them recognition as the fathers of stem cell biology. By the 1990s, advances in tissue engineering and the concept of pluripotency – the ability of a single cell to become many types – gave rise to what we now call regenerative medicine. Yamanaka’s groundbreaking work in 2006, showing that ordinary skin cells could be reprogrammed into induced pluripotent stem cells (iPSCs), removed some of the ethical and immunological barriers that had hampered embryonic stem cell research.
Aesthetic medicine, perhaps surprisingly to some, has been one of the first disciplines to embrace these developments. There are several reasons. Patients increasingly desire natural outcomes: treatments that restore rather than replace. The skin, hair, and connective tissues are visible canvases, allowing researchers and clinicians to observe the effects of regenerative therapies almost in real time. And because aesthetic medicine bridges dermatology, surgery, molecular biology, and bioengineering, it has served as a natural laboratory for testing and refining regenerative protocols.
Platelet-rich plasma (PRP) was one of the earliest regenerative therapies to gain wide clinical use. By concentrating the platelets from a patient’s own blood, PRP delivers a cascade of growth factors – PDGF, TGF-β, VEGF – directly into tissues. Originally used by dentists and orthopaedic surgeons in the 1980s and 90s, PRP migrated into aesthetic practice by the early 2000s, where it became a cornerstone for facial rejuvenation and hair restoration.
Growth factors, naturally occurring proteins and peptides, serve as the body’s molecular architects, orchestrating essential cellular processes like growth, proliferation, differentiation, and survival. As signalling molecules, they bind to specific receptors on target cells, triggering intricate cascades of intracellular events that shape cellular behaviour.
This remarkable specificity allows growth factors to elicit powerful biological responses even at low concentrations, amplifying signals through complex pathways to regulate processes from embryonic development to tissue repair, immune responses, and wound healing. In aesthetic medicine, these biochemical messengers are unlocking new possibilities for skin rejuvenation, hair restoration, and tissue regeneration, offering patients natural, biologically driven solutions to enhance their appearance.
The diversity of growth factors reflects their wide-ranging roles in the body. Epidermal Growth Factor (EGF) drives cell proliferation and differentiation, particularly in epithelial tissues, making it a cornerstone of wound healing and skin repair.
Fibroblast Growth Factors (FGFs) support angiogenesis, tissue repair, and embryonic development, while Platelet-Derived Growth Factor (PDGF), released during clotting, promotes cell migration and proliferation in fibroblasts and smooth muscle cells, aiding tissue reconstruction.
Transforming Growth Factor Beta (TGF-β) regulates proliferation, differentiation, and apoptosis, playing a key role in immune modulation and extracellular matrix production.
Vascular Endothelial Growth Factor (VEGF) is critical for angiogenesis, facilitating blood vessel formation essential for healing and tissue vitality. Insulin-Like Growth Factors (IGFs), meanwhile, promote growth and metabolism across various tissues, ensuring cellular survival.
Each growth factor’s unique function underscores its potential in targeted therapeutic applications. In aesthetic medicine, growth factors are transforming clinical practice by harnessing the body’s regenerative capacity. Incorporated into treatments like platelet-rich plasma (PRP), topical formulations, and exosome-based therapies, they stimulate collagen production, enhance skin elasticity, and promote hair health, delivering natural-looking results. In wound healing, growth factors accelerate tissue repair by recruiting cells that form new blood vessels, collagen, and other regenerative components, making them invaluable for post-procedure recovery in aesthetic treatments.
Beyond aesthetics, growth factors are pivotal in tissue engineering and regenerative medicine, guiding stem cell differentiation and fostering new tissue formation in applications like bone grafts and skin substitutes. However, their role in cancer research highlights a dual nature: while essential for healing, dysregulated growth factors can inadvertently fuel tumour growth, necessitating careful study to develop targeted therapies, such as VEGF inhibitors for certain cancers.
From a personal standpoint, my own journey through this field has paralleled its global rise. Working in Europe, Asia, and beyond, I saw how regenerative therapies moved from the fringes of research into mainstream aesthetic protocols. The development of the Dublin Lift, for example, was born of this era – combining microneedling, platelet concentrates, stem cell–derived products, and light therapy into a single synergistic approach.
What began as a curiosity about the body’s healing mechanisms evolved into protocols now practised by clinicians worldwide. In the evolving landscape of aesthetic medicine, growth factors have emerged as powerful allies, harnessing the body’s natural mechanisms to rejuvenate skin, restore hair, and accelerate healing. These naturally occurring proteins and peptides act as signaling molecules, binding to specific receptors on target cells to stimulate proliferation, differentiation, and extracellular matrix production. Their ability to elicit potent biological effects at low concentrations makes them indispensable for enhancing tissue repair and achieving natural, lasting aesthetic outcomes. By promoting collagen synthesis, angiogenesis, and cellular vitality, growth factors are redefining how clinicians approach beauty, offering patients biologically driven solutions that align with the principles of regenerative medicine.
The Dublin Lift was a composite procedure, often described as an acronym (DUBLiN) for its components: Dermaroller, Ultralase Laser, Blood growth factors (PRP), Light (near red 633nm), and Neurotoxin. It’s designed to target skin ageing by stimulating fibroblast activity, boosting collagen and elastin production, and promoting tissue repair. I developed this approach to harness the body’s natural regenerative capabilities, earning international recognition for its effectiveness
